Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
作者信息
Mvumbi Dieudonné M
机构信息
Biochemistry and Molecular Biology Unit, Department of Basic Sciences, School of Medicine, University of Kinshasa, BP 190 KIN XI Kinshasa, DR Congo.
出版信息
Med Hypotheses. 2020 Oct;143:109912. doi: 10.1016/j.mehy.2020.109912. Epub 2020 May 30.
Abstract
摘要
相似文献
1
Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.在当前新冠疫情背景下大量摄入羟氯喹啉或氯喹啉：对疟疾流行地区可能产生的后果。
Med Hypotheses. 2020 Oct;143:109912. doi: 10.1016/j.mehy.2020.109912. Epub 2020 May 30.
2
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
3
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.氯喹和羟氯喹毒性及处理的简要综述。
West J Emerg Med. 2020 Jun 3;21(4):760-763. doi: 10.5811/westjem.2020.5.47810.
4
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
5
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的紧急授权。
Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9.
6
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).呼吁开展随机对照试验以测试氯喹和羟氯喹作为治疗新型冠状病毒病（COVID-19）药物的疗效
Am J Trop Med Hyg. 2020 May;102(5):932-933. doi: 10.4269/ajtmh.20-0230.
7
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎（SARS-CoV-2感染）时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
8
Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?用于治疗新冠肺炎的氯喹或羟氯喹：心脏毒性是一个值得关注的问题吗？
J Am Heart Assoc. 2020 Jun 16;9(12):e016887. doi: 10.1161/JAHA.120.016887. Epub 2020 May 28.
9
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
10
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.用于治疗新冠肺炎的氯喹/羟氯喹引发室性心律失常的风险：是否应该使用该药？
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
引用本文的文献
1
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review.刚果民主共和国恶性疟原虫疟疾的耐药性情况：一项绘图系统评价。
Trop Med Health. 2023 Nov 15;51(1):64. doi: 10.1186/s41182-023-00551-7.
2
Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.与 COVID-19 大流行和早期应对相关的健康风险竞争：范围综述。
PLoS One. 2022 Aug 29;17(8):e0273389. doi: 10.1371/journal.pone.0273389. eCollection 2022.
3
Public health-relevant consequences of the COVID-19 pandemic on malaria in sub-Saharan Africa: a scoping review.新冠疫情对撒哈拉以南非洲疟疾的公共卫生影响：范围综述。
Malar J. 2021 Aug 11;20(1):339. doi: 10.1186/s12936-021-03872-2.
4
Competing Health Risks Associated with the COVID-19 Pandemic and Early Response: A Scoping Review.与2019年冠状病毒病大流行及早期应对相关的相互竞争的健康风险：一项范围综述
medRxiv. 2021 Dec 15:2021.01.07.21249419. doi: 10.1101/2021.01.07.21249419.
5
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.羟氯喹在新冠大流行时代：为了合理预防 SARS-CoV-2 感染而进行的探索。
Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16. doi: 10.1080/14787210.2020.1799785. Epub 2020 Aug 16.
6
COVID-19 and Plasmodium vivax malaria co-infection.新型冠状病毒肺炎与间日疟原虫疟疾合并感染
IDCases. 2020 Jun 20;21:e00879. doi: 10.1016/j.idcr.2020.e00879. eCollection 2020.
本文引用的文献
1
Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter.疟原虫氯喹耐药转运蛋白的结构与进化分析。
Sci Rep. 2020 Mar 16;10(1):4842. doi: 10.1038/s41598-020-61181-1.
2
Chloroquine for the 2019 novel coronavirus SARS-CoV-2.氯喹用于2019新型冠状病毒SARS-CoV-2。
Int J Antimicrob Agents. 2020 Mar;55(3):105923. doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15.
3
High Prevalence of Plasmodium falciparum Infection in Asymptomatic Individuals from the Democratic Republic of the Congo.刚果民主共和国无症状个体中恶性疟原虫感染的高流行率。
Malar Res Treat. 2016;2016:5405802. doi: 10.1155/2016/5405802. Epub 2016 Jan 28.
Zotero 插件